Lind L. Apolipoprotein B/A1 and risk of cardiovascular disease. Lancet. 2008;372(9634):185-6.Lind L. Apolipoprotein B/A1 and risk of cardiovascular disease. Lancet. 2008; 372:1185-186.Lind L (2008) Apolipoprotein B/A1 and risk of cardiovascular disease. Lancet 372:185-186...
recent general population studies which have provided insight into the predictive value of apolipoprotein B levels for ischemic cardiovascular disease, and the effects of rare and common APOB alleles on plasma levels of apolipoprotein B, lipid metabolism, and risk of ischemic cardiovascular disease. ...
Apolipoproteins are specialized proteins that regulate lipoprotein metabolism and influence normal human vascular biology and atherosclerotic cardiovascular disease. Clinically important apolipoproteins include apolipoprotein B-100, apolipoprotein B-48, apolipoprotein A-I, apolipoprotein C-II, apolipoprotein C-III...
First recognized as a major determinant in lipoprotein metabolism and cardiovascular disease, apolipoprotein (apo) E has emerged as an important molecule i... RW Mahley,SC Rall - 《Annu Rev Genomics Hum Genet》 被引量: 3189发表: 2000年 The role of interleukin-4 and interleukin-12 in the pr...
Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiol. 2019;4(12):1287-1295. doi:10.1001/jamacardio.2019.3780ArticlePubMedGoogle ScholarCrossref 16. Mach F, Baigent C, Catapano AL, et al; ESC Scientific Document Group. 2019 ESC/EAS guidelines ...
Apolipoprotein B is the major constituent of the atherogenic particles VLDL, IDL, and LDL. The plasma concentration of apolipoprotein B can be measured and has been examined for its function as a surrogate marker for cardiovascular risk. In addition to apo B, non-high-density lipoprotein cholester...
Subendothelial retention of apolipoprotein B containing lipoproteins is a necessary initiating eve... M Benn - 《Atherosclerosis》 被引量: 165发表: 2009年 A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease The focus of this review is on the role of ...
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ. 2009;338:b9219221140PubMedGoogle ScholarCrossref 25. Treatment of HDL to reduce the incidence of vascular events: HPS2-THRIVE. ...
This study sought to examine the relationship between baseline and on-study apolipoproteins (apo) A-1 and B and lipoprotein(a) [Lp(a)] levels and the development of subsequent cardiovascular (CV) events in the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Trigl...
Results obtained largely from case-control studies have suggested that an elevated plasma concentration of apolipoprotein (apo) B may be considered an important risk factor for ischemic heart disease (IHD). Prospective data on the relevance of measuring apo A-I and apo B levels in the assessment...